Indaptus Therapeutics, Inc. (INDP)
1.76
+0.11
(+6.67%)
USD |
NASDAQ |
Feb 13, 16:00
1.69
-0.07
(-3.98%)
After-Hours: 20:00
Indaptus Therapeutics EPS Diluted (Quarterly) : -2.984 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Dynavax Technologies Corp. | 0.2063 |
| Citius Pharmaceuticals, Inc. | -0.3824 |
| Applied Therapeutics, Inc. (DELISTED) | -0.1305 |
| Dermata Therapeutics, Inc. | -1.648 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.975M |
| Total Expenses (Quarterly) | 2.975M |
| Enterprise Value | -4.809M |
| Earnings Yield | -1.30K% |
| Normalized Earnings Yield | -1228.28 |